Fed. Circ. Blocks Generic Sales Of AstraZeneca's Pulmicort
By Ama Sarfo ( May 28, 2013, 12:41 PM EDT) -- The Federal Circuit on Friday blocked four generic-drug makers from launching no-name versions of AstraZeneca PLC's Pulmicort Respules pediatric asthma medication while the pharmaceutical giant appeals a lower court ruling in New Jersey that one of its patents is invalid and the other hasn't been infringed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.